Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Notice to Readers HIV Postexposure Prophylaxis Registry Closing

Effective December 31, 1998, enrollment of new health-care workers (HCWs) in the Human Immunodeficiency Virus Postexposure Prophylaxis (HIV PEP) Registry ceased; the goals and objectives of the registry had been met. In addition, continuation of the registry appeared redundant with other ongoing surveillance programs.

The HIV PEP Registry was established in October 1996 as a prospective surveillance project to monitor adverse events associated with HIV PEP in HCWs after occupational HIV exposures. It was a collaborative project managed by CDC and two pharmaceutical companies, Glaxo Wellcome Inc. and Merck & Co., Inc. * A designated third party, a contract research organization, responsible for registration and follow-up, served as the data coordination center.

The registry data have shown that HCWs for whom HIV PEP is prescribed have not reported unusual adverse events (i.e., those not included in the prescribing information or literature) with these treatments. Data suggest that careful counseling about drug toxicity may be necessary to improve compliance with PEP among exposed HCWs. Six-week follow-up of enrolled HCWs will be completed.

Additional information about the registry is available from the HIV PEP Registry, telephone (toll-free) (888) 737-4448 until June 30, 1999, and afterwards from CDC's Hospital Infections Program, telephone (404) 639-6425. Serious adverse events or product problems can be reported to the Food and Drug Administration's MedWatch program, telephone (800) 332-1088; fax (800) 332-0178; address: HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787; or by the World-Wide Web, less than http://www.fda.gov/medwatchgreater than .

  • Use of trade names and commercial sources does not imply endorsement by the U.S. Department of Health and Human Services or CDC.




Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #